WHO publishes Draft Working Document on Chromatography
Recommendation

Monday, 21 September 2026 14.00 - 16.00 h
Regulatory Landscape: ECHA, USP, Pharmacopoeias and FDA Enforcement
The World Health Organization (WHO) has published a draft proposal for inclusion in The International Pharmacopoeia. The new chapter 1.14.1 Chromatography shall replace the chapters 1.14.1 Thin-layer chromatography, 1.14.4 High-performance liquid chromatography and 1.14.5 Gas Chromatography.
The first draft working document was prepared based on the internationally-harmonized text developed by the Pharmacopoeial Discussion Group (PDG).
The following aspects are covered:
- Introduction: The introduction contains a short section on the definition of chromatography.
- Definitions: The section contains definitions and calculations of common parameters, e.g.
- Distribution constant
- Dwell volume
- Peak-to-valley ratio
- Plate height
- Plate number
- Relative retardation
- Resolution
- Separation factor
- Signal-to-noise ratio
- Symmetry factor
- System repeatability - System suitability: In this section, generally applicable requirements for system suitability are given. Only liquid chromatography and gas chromatography are covered.
- Adjustment of chromatographic conditions: The extent to which the various parameters of a chromatographic test may be adjusted without fundamentally modifying the pharmacopoeial analytical procedures are listed.
- Quantitation: The quantitation approaches that may be used in general texts or monographs are described.
- Other considerations: The new chapter concludes with some general aspects on
- Detector response
- Interfering peaks
- Measurement of peaks
- Reporting threshold
The draft working document (QAS/21.905) is available as a PDF file on the WHO homepage. Comments can be submitted until 25 March 2022.
Related GMP News
03.09.2026USP Article: Supporting the Detection of Asbestos in Pharmaceutical Talc
02.09.2026USP Publishes Comments Received on Chapter <320>
26.08.2026New USP Requirements for Asbestos Testing in Pharmaceutical Talc
19.08.2026FDA Warning Letter: Averaging Data to Override OOS Findings
12.08.2026ECA's Analytical Control Group Publishes Detailed Report on OOS Survey
12.08.2026BP Publishes Key Insights on Limits in Chromatographic Tests


